Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN)
Status:
Recruiting
Trial end date:
2023-06-14
Target enrollment:
Participant gender:
Summary
This is a 2-part study in PBC participants with cholestatic pruritus and will evaluate the
efficacy, safety and impact on health-related quality of life of linerixibat compared with
placebo.